v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:              
Net Income (Loss) $ (7,460) $ (9,552) $ (5,891) $ (6,026) $ (28,349) $ (17,754)  
Adjustments to reconcile net loss to net cash used in from operating activities:              
(Recovery of) provision for bad debt expense         (657) 217  
Depreciation and amortization         339 565  
Amortization of intangible assets 503   0   1,510 0  
Share-based compensation         6,369 6,199  
Payment-in-kind interest         1,609 490  
Amortization of debt issuance costs and original issue discounts         154 60  
Amortization of lease right of use assets, net of accretion in lease liabilities         2,260 821  
Deferred income taxes         (49) 0  
Increase (decrease) in cash resulting from changes in:              
Accounts receivable         (811) 497  
Inventory, net         (1,202) (16)  
Prepaid expenses and other current assets         (40) (696)  
Other assets         (235) (192)  
Accounts payable and accrued expenses         (268) (1,515)  
Lease liabilities         (1,321) (716)  
Contract liabilities         (272) (69)  
Accrued interest payable         869 264  
Net cash used in operating activities (20,100)       (20,094) (11,845) $ (23,900)
Cash flows from investing activities:              
Purchases of property and equipment         (996) (473)  
Net cash used in investing activities         (996) (473)  
Cash flows from financing activities:              
Proceeds from offering of common stock, net of offering costs         0 3,263  
Proceeds from issuance of note payable, net of financing costs and discount         0 28,653  
Proceeds from stock option exercises         654 49  
Payments for taxes related to net share settlement of equity awards         (1,993) (1,661)  
Proceeds from issuance of common stock under at-the-market equity offering program, net of issuance costs of $0.5 million 22,000       22,020 0  
Proceeds from issuance of common stock under employee stock purchase plan         546 311  
Net cash provided by financing activities         21,227 30,615  
Net change in cash, cash equivalents and restricted cash         137 18,297  
Cash, cash equivalents and restricted cash, beginning of period   $ 46,973   $ 20,104 46,973 20,104 20,104
Cash, cash equivalents and restricted cash, end of period 47,110   38,401   47,110 38,401 46,973
Cash and cash equivalents 46,184   38,221   46,184 38,221 45,923
Restricted cash included in other current assets and other assets, non-current 926   180   926 180  
Total cash, cash equivalents and restricted cash $ 47,110   $ 38,401   47,110 38,401 $ 46,973
Cash paid for:              
Income taxes         34 69  
Interest         1,609 490  
Non-cash investing and financing transactions:              
Property and equipment included in accounts payable and other accrued liabilities         329 0  
Net transfers of reusable components between property and equipment and inventory         307 262  
Right-of-use assets obtained in exchange for operating lease liabilities         $ 13,882 $ 3,309